Search Results - "Brancato, Sam"

Epidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer by Railkar, Reema, Krane, L Spencer, Li, Q Quentin, Sanford, Thomas, Siddiqui, Mohammad Rashid, Haines, Diana, Vourganti, Srinivas, Brancato, Sam J, Choyke, Peter L, Kobayashi, Hisataka, Agarwal, Piyush K

“…The use of light as a means of therapy for bladder cancer has a long history but has been hampered by a lack of tumor specificity and therefore, damage to the…”
Get full text

Comparison of Postural Ergonomics Between Laparoscopic and Robotic Sacrocolpopexy: A Pilot Study by Tarr, Megan E., MD, MS, Brancato, Sam J., MD, Cunkelman, Jacqueline A., MD, MPH, Polcari, Anthony, MD, Nutter, Benjamin, MS, Kenton, Kimberly, MD, MS

“…Abstract Study Objective To compare resident, fellow, and attending urologic and gynecologic surgeons' musculoskeletal and mental strain during laparoscopic…”
Get full text

Targeted therapies in urothelial carcinoma by Ghosh, Monalisa, Brancato, Sam J, Agarwal, Piyush K, Apolo, Andrea B

“…PURPOSE OF REVIEWGreater understanding of the biology and genetics of urothelial carcinoma is helping to identify and define the role of molecules and pathways…”
Get full text

Nonmuscle invasive bladder cancer： a primer on immunotherapy by Maruf, Mahir, Brancato, Sam J, Agarwal, Piyush K

“…Intravesical Bacillus Calmette-Guerin （BCG） has long been the gold standard treatment of nonmuscle invasive bladder cancer. Recently, there has been an…”
Get full text

Lyso-thermosensitive liposomal doxorubicin for treatment of bladder cancer by Mikhail, Andrew S, Negussie, Ayele H, Pritchard, William F, Haemmerich, Dieter, Woods, David, Bakhutashvili, Ivane, Esparza-Trujillo, Juan, Brancato, Sam J, Karanian, John, Agarwal, Piyush K, Wood, Bradford J

“…To evaluate lyso-thermosensitive liposomal doxorubicin (LTLD, ThermoDox ) in combination with loco-regional mild hyperthermia (HT) for targeted drug delivery…”
Get more information

Lymph node dissection during radical cystectomy following prior radiation therapy: results from the SEER database by Maruf, Mahir, Sidana, Abhinav, Purnell, Stephanie, Jain, Amit L., Brancato, Sam J., Agarwal, Piyush K.

“…Purpose Population studies of patients undergoing radical cystectomy (RC) for bladder cancer (BC) suggest that a more extended lymph node dissection (LND)…”
Get full text

Novel immunotherapeutic approaches to the treatment of urothelial carcinoma by Muthigi, Akhil, George, Arvin K., Brancato, Sam J., Agarwal, Piyush K.

“…Immunotherapy has long played a role in urothelial cancers with the use of bacille Calmette Guérin (BCG) being a mainstay in the treatment of nonmuscle…”
Get full text

Financial Relationships between Urologists and Industry: An Analysis of Open Payments Data by Maruf, Mahir, Sidana, Abhinav, Fleischman, William, Brancato, Sam J, Purnell, Stephanie, Agrawal, Shantanu, Agarwal, Piyush K

“…The Open Payments Program was enacted to increase transparency of financial relationships between physicians and the medical device and pharmaceutical…”
Get full text

Evolving immunotherapy strategies in urothelial cancer by Brancato, Sam J, Lewi, Keidren, Agarwal, Piyush K

“…The treatment of nonmuscle-invasive urothelial carcinoma with bacillus Calmette-Guérin (BCG) represents the importance of immunotherapy in the treatment of…”
Get more information

Case Presentation: Lung Consolidation as Sequelae of BCG Sepsis After Combined Intravesical and Intraurethral BCG by Strich, Jeffrey R., Brancato, Sam, Dolan, Rebecca, Maruf, Mahir, Siddiqui, Mohammad R., Sanford, Thomas, Zerbe, Christa, Agarwal, Piyush K.

“…BCG sepsis is rarely seen with modern intravesical therapy and therefore its presentation may not be apparent to recently trained urologists. We describe BCG…”
Get full text

Effects of mixture casting Nafion ® with quaternary ammonium bromide salts on the ion-exchange capacity and mass transport in the membranes by Schrenk, Matthew J, Villigram, Robert E, Torrence, Nicholas J, Brancato, Sam J, Minteer, Shelley D

“…Nafion ® has been used to modify electrodes for a wide variety of electrochemical applications. This research studies how the physical properties of Nafion ®…”
Get full text

Electrochemical Studies of Surface-Modified Glass Bead/Nafion Composites by Brancato, Sam J, Minteer, Shelley D

“…In the past decade, electrochemists have begun modifying electrode surfaces with polymer composites. Each of those composites had advantages over the standard…”
Get full text

Continuous Monitoring of Enzyme Reactions on a Microchip:  Application to Catalytic RNA Self-Cleavage by Paxon, Tracy L, Brown, Trevor S, Lin, Hsiao-yu Nancy, Brancato, Sam J, Roddy, Elizabeth S, Bevilacqua, Philip C, Ewing, Andrew G

“…Kinetic analysis of RNA enzymes, or ribozymes, typically involves the tedious process of collecting and quenching reaction time points and then fractionating…”
Get full text

Transplantation of cadaveric pediatric duel en bloc renal allografts in a patient with elevated factor VIII and IX levels by Brancato, Sam J, Hoyt, Daniel S, Ross, Jr, Gilbert, Wakefield, Mark R

Get more information

Study EV-103: Neoadjuvant treatment with enfortumab vedotin monotherapy in cisplatin-ineligible patients with muscle invasive bladder cancer (MIBC)—2-year event-free survival and safety data for Cohort H by O'Donnell, Peter H., Hoimes, Christopher J., Rosenberg, Jonathan E., Petrylak, Daniel P., Mar, Nataliya, Barata, Pedro C., Srinivas, Sandy, Gourdin, Theodore Stewart, Henry, Elizabeth, Bilen, Mehmet Asim, George, Saby, Rao, Santosh, Assikis, Vasileios J., Burgess, Earle F, Lewis, Brian E., Bowman, I. Alex, Brancato, Sam Joseph, Mildiner-Earley, Shirly, Zhu, Yalin, Flaig, Thomas W.

“…4564 Background: For patients (pts) with MIBC who are cisplatin-ineligible and undergoing radical cystectomy and pelvic lymph node dissection (RC+PLND), no…”
Get full text

Medications for urologic malignancies in the open payments data: Financial relationships between industry and urologists by Maruf, Mahir, Sidana, Abhinav, Purnell, Stephanie, Fleischman, William, Brancato, Sam Joseph, Agrawal, Shantanu, Agarwal, Piyush K.

“…Abstract only 74 Background: The Open Payments program was enacted to increase transparency of the financial relationships between physicians and the…”
Get full text

MP16-14 CLINICAL OUTCOMES OF A RANDOMIZED, PROSPECTIVE, PHASE II STUDY TO DETERMINE THE EFFICACY OF BACILLUS CALMETTE-GUERIN (BCG) GIVEN IN COMBINATION WITH PANVAC VERSUS BCG GIVEN ALONE IN ADULTS WITH HIGH GRADE BCG-REFRACTORY NON-MUSCLE INVASIVE BLADDER CANCER by Saoud, Ragheed, Telfer, Siobhan, Maruf, Mahir, Singer, Eric, Weiss, Robert, Jang, Thomas, Elsamra, Sammy, Marino, Maria, Valera, Vladimir, Rodriguez, Beatriz Walter, Railkar, Reema, Dolan, Rebecca, Bellfield, Sonia, Stamatakis, Lambros, Shih, Joanna, Brancato, Sam, Donohue, Renee, Navarro, Cesar Pico, Apolo, Andrea, Gulley, James, Schlom, Jeffrey, Agarwal, Piyush

Get full text

Long-term follow-up of clinical presentation and outcomes of patients with urinary bladder paragangliomas by Rayn, Kareem, Weintraub, Michael Daniel, Pena-LaGrave, Gustavo, Gold, Samuel, Hale, Graham R., Bloom, Jonathan, Brancato, Sam Joseph, Agarwal, Piyush K.

“…Abstract only 507 Background: Urinary bladder paragangliomas (UBPGLs) are extremely rare, accounting for less than 6% of paragangliomas (PGLs) and 0.06% of…”
Get full text

Characterization of urinary bladder paragangliomas in patients with germline mutations by Rayn, Kareem, Weintraub, Michael Daniel, Pena-La Grave, Gustavo R, Hale, Graham R., Gold, Samuel, Bloom, Jonathan, Brancato, Sam Joseph, Agarwal, Piyush K.

“…Abstract only 508 Background: Data on the genetic characteristics of patients with urinary bladder paragangliomas (UBPGLs) is extremely limited. The primary…”
Get full text

Abstract 3311: Molecular targeted photoimmunotherapy as a treatment for bladder cancer by Railkar, Reema, Li, Quentin, Vourganti, Srinivas, Brancato, Sam J., Choyke, Peter L., Kobayashi, Hisataka, Agarwal, Piyush K.

“…Introduction: Bladder cancer (BCa) is a common cancer and is the most expensive malignancy to treat from diagnosis to death. Although no new therapies have…”
Get full text